Table 1 Patient characteristics.
Characteristics | No. (%) |
|---|---|
Median age, years(range) | 59 (37–78) |
Advanced or metastatic | |
De novo stage IV | 2 (7.4) |
Metastatic | 25 (92.6) |
DFI | |
≤24 mo | 4 (14.8) |
>24 mo | 21 (77.8) |
No. of metastatic sites | |
1 | 3 (11.1) |
2 | 10 (37.0) |
≥3 | 14 (51.9) |
Metastatic sites | |
Visceral | 15 (55.6) |
Liver | 6 (22.2) |
Lung | 12 (44.4) |
Non-visceral | 12 (44.4) |
Prior palliative chemotherapy | |
Yes | 8 (29.6) |
No | 19 (70.4) |
Lines of endocrine therapy | |
1 | 19 (70.4) |
2 | 4 (14.8) |
≥3 | 4 (14.8) |
